Literature DB >> 17351658

Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.

K Quirk1, D J Roberts, P G Strange.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this report is to study mechanisms of G protein activation by agonists. EXPERIMENTAL APPROACH: The association and dissociation of guanosine 5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS) binding at G proteins in membranes of CHO cells stably transfected with the human dopamine D(2short) receptor was studied in the presence of a range of agonists. KEY
RESULTS: Binding of [(35)S]GTPgammaS was dissociable in the absence of agonist and dissociation was accelerated both in rate and extent by dopamine, an effect which was blocked by the dopamine D(2) receptor antagonist raclopride and by suramin, which inhibits receptor/G protein interaction. A range of agonists of varying efficacy increased the rate of dissociation of [(35)S]GTPgammaS binding, with the more efficacious agonists resulting in faster dissociation. Agonists were able to dissociate about 70% of the pre-bound [(35)S]GTPgammaS, leaving a component which may not be accessible to the agonist-bound receptor. The dissociable component of the [(35)S]GTPgammaS binding was reduced with longer association times and increased [(35)S]GTPgammaS concentrations. CONCLUSIONS AND IMPLICATIONS: These data are consistent with [(35)S]GTPgammaS binding being initially to receptor-linked G proteins and then to G proteins which have separated from the agonist bound receptor. Under the conditions used typically for [(35)S]GTPgammaS binding assays, therefore, much of the agonist-receptor complex remains in proximity to G proteins after they have been activated by agonist.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351658      PMCID: PMC2012977          DOI: 10.1038/sj.bjp.0707197

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.

Authors:  J Wilson; H Lin; D Fu; J A Javitch; P G Strange
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

2.  Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese hamster ovary cell membranes; 1. Mathematical analysis of catalytic G protein activation.

Authors:  M Waelbroeck
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

3.  Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.

Authors:  A Alt; M J Clark; J H Woods; J R Traynor
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 4.  The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

Authors:  C Harrison; J R Traynor
Journal:  Life Sci       Date:  2003-12-12       Impact factor: 5.037

5.  Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.

Authors:  John R Traynor; Mary J Clark; Ann E Remmers
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

6.  Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.

Authors:  Adrian Newman-Tancredi; Didier Cussac; Yann Quentric; Manuelle Touzard; Laurence Verrièle; Nathalie Carpentier; Mark J Millan
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

7.  Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins.

Authors:  K Wenzel-Seifert; R Seifert
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

8.  Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.

Authors:  H Lin; S G N Saisch; P G Strange
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

10.  Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor.

Authors:  Sarah L Payne; Anette M Johansson; Philip G Strange
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

View more
  2 in total

Review 1.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Pathway-selective antagonism of proteinase activated receptor 2.

Authors:  J Y Suen; A Cotterell; R J Lohman; J Lim; A Han; M K Yau; L Liu; M A Cooper; D A Vesey; D P Fairlie
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.